Advertisement

Complementary and coordinate markers for detection of epithelial ovarian cancers

  • R. C. BastJr.
  • F. Xu
  • R. P. Woolas
  • Y. Yu
  • M. Conaway
  • K. O’Briant
  • L. Daly
  • D. H. Oram
  • A. Berchuck
  • D. L. Clarke-Pearson
  • J. T. Soper
  • G. Rodriguez
  • I. J. Jacobs

Abstract

Early detection of ovarian cancer might substantially improve results of therapy. After careful surgical staging, 90% of patients with stage I disease and 70% of patients with stage II disease can be cured with currently available therapy. Epithelial ovarian cancer may be one of the malignancies that lends itself to early detection with a blood test. Antigens shed from the ovarian surface into the peritoneal cavity are taken up by diaphragmatic lymphatics and pass through the alternative thoracic duct into the venous circulation. In early work by Knauf and Urbach [1] the OCA antigen could be detected in 70% of patients with early stage disease. OCA was also found in approximately 10% of healthy individuals, precluding its use in screening. This observation did, however, suggest that shed tumor products could be found in the circulation in an early stage of disease.

Keywords

Ovarian Cancer Transvaginal Sonography Pelvic Mass Ovarian Epithelial Cancer Cell Transabdominal Ultrasound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Knauf, S. and Urbach, G.I. (1980) A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumorassociated antigen OCA. Am. J. Obstet. Gynecol., 138,1222–3.PubMedGoogle Scholar
  2. 2.
    Bast, R.C. Jr., Klug, T.L., St John, E. et al., (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med., 309, 883–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Bast, R.C. Jr., Siegal, P.P., Runowicz, C. et al., (1985) Elevation of serum CA 125 prior to diagnosis of epithelial ovarian carcinoma. Gynecol. Oncol., 22,115–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Zurawski, V.R. Jr., Orjaseter, H., Andersen, A. and Jellum, E. (1988) Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int. J. Cancer, 42, 677–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Jacobs, I. and Bast, R.C. Jr. (1989) The CA 125 tumour-associated antigen: a review of the literature. Hum. Reprod., 4,1–12.PubMedGoogle Scholar
  6. 6.
    Einhorn, N., Sjovall, K., Knapp, R.C. et al, (1992) Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet. Gynecol., 80,14–18.PubMedGoogle Scholar
  7. 7.
    Ramakrishnan, S., Xu, F.J., Brandt, S.J. et al, (1989) Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J. Clin. Invest., 83, 921–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Xu, F.J., Ramakrishnan, S., Daly, L. et al, (1991) Increased serum levels of macrophage colony- stimulating factor in ovarian cancer. Am. J. Obstet. Gynecol., 165,1356–62.PubMedGoogle Scholar
  9. 9.
    Xu, F.J., Yu, Y.H., Li, B.Y. et al, (1991) Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells. Cancer Res., 51, 4012–19.PubMedGoogle Scholar
  10. 10.
    Xu, F.J., Yu, Y.A., Daly, L. et al, (1993) The OVXl radioimmunoassay complements CA 125 for predicting the presence of residual ovarian carcinoma at second look surgical surveillance procedures. J. Clin. Oncol., 11, 1506–10.PubMedGoogle Scholar
  11. 11.
    Woolas, R.P., Xu, F.J., Jacobs, I.J.et al, (1993) Elevation of multiple serum markers in stage I ovarian cancer. J. Natl Cancer Inst., in press.Google Scholar
  12. 12.
    Jacobs, L, Prys Davies, A. and Oram, D. (1992) Role of CA-125 in screening for ovarian cancer. In Ovarian Cancer 2: Biology, Diagnosis and Management, (eds P. Sharp, W.P. Mason and W. Creasman), Chapman & Hall, London, pp. 265–76.Google Scholar
  13. 13.
    Woolas, R., Jacobs, I.J., Xu, F.J. et al, (1993) Serum levels of CA 125, M-CSP and OVXl in stage I and preclinical ovarian cancer. Proc. Am. Sac. Clin. Oncol., 12,110.Google Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • R. C. BastJr.
  • F. Xu
  • R. P. Woolas
  • Y. Yu
  • M. Conaway
  • K. O’Briant
  • L. Daly
  • D. H. Oram
  • A. Berchuck
  • D. L. Clarke-Pearson
  • J. T. Soper
  • G. Rodriguez
  • I. J. Jacobs

There are no affiliations available

Personalised recommendations